Edwards Lifesciences Corp (EW)vsWORK Medical Technology Group LTD Ordinary Shares (WOK)
EW
Edwards Lifesciences Corp
$82.67
+1.20%
HEALTHCARE · Cap: $48.01B
WOK
WORK Medical Technology Group LTD Ordinary Shares
$1.21
+6.64%
HEALTHCARE · Cap: $1.46M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 61508% more annual revenue ($6.07B vs $9.85M). EW leads profitability with a 17.7% profit margin vs -10.9%. EW earns a higher WallStSmart Score of 55/100 (C).
EW
Buy55
out of 100
Grade: C
WOK
Avoid29
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.67
$70.36 premium
Intrinsic value data unavailable for WOK.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
Grey zone — moderate risk
Smaller company, higher risk/reward
ROE of -6.5% — below average capital efficiency
Revenue declined 14.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : WOK
The strongest argument for WOK centers on Price/Book.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.
Bear Case : WOK
The primary concerns for WOK are Altman Z-Score, Market Cap, Return on Equity.
Key Dynamics to Monitor
EW profiles as a mature stock while WOK is a turnaround play — different risk/reward profiles.
EW is growing revenue faster at 13.3% — sustainability is the question.
EW generates stronger free cash flow (354M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
EW scores higher overall (55/100 vs 29/100), backed by strong 17.7% margins and 13.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →WORK Medical Technology Group LTD Ordinary Shares
HEALTHCARE · MEDICAL DEVICES · USA
WORK Medical Technology Group Ltd is a prominent player in the medical technology sector, specializing in the research, development, and commercialization of innovative healthcare solutions. The company focuses on creating advanced medical devices that significantly improve patient outcomes and meet pressing global healthcare challenges. With a strong dedication to quality and a diverse product portfolio, WORK is strategically positioned for sustained growth, making it an appealing investment choice for institutional investors aiming to capitalize on transformative developments in the healthcare industry.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?